Antineoplastic and immunomodulating agents (Польша - Тендер #47436767)

1. Section I
   1. Name and addresses
      Szpital Specjalistyczny im. Jędrzeja Śniadeckiego w Nowym Sączu
      ul. Młyńska 10
      Nowy Sącz
      33-300
      Poland
      Telephone: +48 184436635
      E-mail: zamowieniapubliczne@szpitalnowysacz.pl
      Fax: +48 184436635
      
   2. Joint procurement
      
   3. Communication
      The procurement documents are available for unrestricted and full direct access, free of charge, at
      https://ezamowienia@gov.pl
      Additional information can be obtained from the abovementioned addresselectronically via: https://ezamowienia@gov.pl
      
      
   4. Type of the contracting authority:
      Body governed by public law
      
   5. Main activity:
      Health
      
2. Section II
   1. Scope of the procurement:
      1. Title:
         

         Dostawa produktów leczniczych

         Reference number: DA.261.1.56.2023
         
      2. Main CPV code:
         33652000
         
      3. Type of contract:
         Supplies
         
      4. Short description:
         

         Przedmiot zamówienia obejmuje dostawy produktów leczniczych- 91 części szczegółowo opisanych w załączniku nr 2 do SWZ.

      5. Estimated total value:
         Value excluding VAT: 30 274 102.29 PLN
         
      6. Information about lots:
         all lots
   2. Description
      1. Title:
         

         Cetuksymab

         Lot No: 1
         
      2. Additional CPV code(s):
         33652000
         
      3. Place of performance:
         Main site or place of performance:

         siedziba zamawiającego- Apteka szpitalna

      4. Description of the procurement:
         

         Cetuksymab

      5. Award criteria:
         
      6. Estimated value:
         
         
      7. Duration of the contract, framework agreement or dynamic purchasing system:
         Duration in months: 12
         This contract is subject to renewal: no
         
      8. Information about the limits on the number of candidates to be invited:
         
      9. Information about variants:
         Variants will be accepted: no
         
      10. Information about options:
          Options: no
      11. Information about electronic catalogues:
          
          
      12. Information about European Union funds:
          The procurement is related to a project and/or programme financed by European Union funds: no
      13. Additional information:
          
      14. Title:
          

          Panitumumab

          Lot No: 2
          
      15. Additional CPV code(s):
          33652000
          
      16. Place of performance:
          Main site or place of performance:

          siedziba zamawiającego- Apteka szpitalna

      17. Description of the procurement:
          

          Panitumumab

      18. Award criteria:
          
      19. Estimated value:
          
          
      20. Duration of the contract, framework agreement or dynamic purchasing system:
          Duration in months: 12
          This contract is subject to renewal: no
          
      21. Information about the limits on the number of candidates to be invited:
          
      22. Information about variants:
          Variants will be accepted: no
          
      23. Information about options:
          Options: no
      24. Information about electronic catalogues:
          
          
      25. Information about European Union funds:
          The procurement is related to a project and/or programme financed by European Union funds: no
      26. Additional information:
          
      27. Title:
          

          Aflibercep

          Lot No: 3
          
      28. Additional CPV code(s):
          33652000
          
      29. Place of performance:
          Main site or place of performance:

          siedziba zamawiającego- Apteka szpitalna

      30. Description of the procurement:
          

          Aflibercep

      31. Award criteria:
          
      32. Estimated value:
          
          
      33. Duration of the contract, framework agreement or dynamic purchasing system:
          Duration in months: 12
          This contract is subject to renewal: no
          
      34. Information about the limits on the number of candidates to be invited:
          
      35. Information about variants:
          Variants will be accepted: no
          
      36. Information about options:
          Options: no
      37. Information about electronic catalogues:
          
          
      38. Information about European Union funds:
          The procurement is related to a project and/or programme financed by European Union funds: no
      39. Additional information:
          
      40. Title:
          

          Triflurydyna + Typiracyl

          Lot No: 4
          
      41. Additional CPV code(s):
          33652000
          
      42. Place of performance:
          Main site or place of performance:

          siedziba zamawiającego- Apteka szpitalna

      43. Description of the procurement:
          

          Triflurydyna + Typiracyl

      44. Award criteria:
          
      45. Estimated value:
          
          
      46. Duration of the contract, framework agreement or dynamic purchasing system:
          Duration in months: 12
          This contract is subject to renewal: no
          
      47. Information about the limits on the number of candidates to be invited:
          
      48. Information about variants:
          Variants will be accepted: no
          
      49. Information about options:
          Options: no
      50. Information about electronic catalogues:
          
          
      51. Information about European Union funds:
          The procurement is related to a project and/or programme financed by European Union funds: no
      52. Additional information:
          
      53. Title:
          

          Ipilimumabum

          Lot No: 5
          
      54. Additional CPV code(s):
          33652000
          
      55. Place of performance:
          Main site or place of performance:

          siedziba zamawiającego- Apteka szpitalna

      56. Description of the procurement:
          

          Ipilimumabum

      57. Award criteria:
          
      58. Estimated value:
          
          
      59. Duration of the contract, framework agreement or dynamic purchasing system:
          Duration in months: 12
          This contract is subject to renewal: no
          
      60. Information about the limits on the number of candidates to be invited:
          
      61. Information about variants:
          Variants will be accepted: no
          
      62. Information about options:
          Options: no
      63. Information about electronic catalogues:
          
          
      64. Information about European Union funds:
          The procurement is related to a project and/or programme financed by European Union funds: no
      65. Additional information:
          
      66. Title:
          

          Niwolumab

          Lot No: 6
          
      67. Additional CPV code(s):
          33652000
          
      68. Place of performance:
          Main site or place of performance:

          siedziba zamawiającego- Apteka szpitalna

      69. Description of the procurement:
          

          Niwolumab

      70. Award criteria:
          
      71. Estimated value:
          
          
      72. Duration of the contract, framework agreement or dynamic purchasing system:
          Duration in months: 12
          This contract is subject to renewal: no
          
      73. Information about the limits on the number of candidates to be invited:
          
      74. Information about variants:
          Variants will be accepted: no
          
      75. Information about options:
          Options: no
      76. Information about electronic catalogues:
          
          
      77. Information about European Union funds:
          The procurement is related to a project and/or programme financed by European Union funds: no
      78. Additional information:
          
      79. Title:
          

          Pembrolizumab

          Lot No: 7
          
      80. Additional CPV code(s):
          33652000
          
      81. Place of performance:
          Main site or place of performance:

          siedziba zamawiającego- Apteka szpitalna

      82. Description of the procurement:
          

          Pembrolizumab

      83. Award criteria:
          
      84. Estimated value:
          
          
      85. Duration of the contract, framework agreement or dynamic purchasing system:
          Duration in months: 12
          This contract is subject to renewal: no
          
      86. Information about the limits on the number of candidates to be invited:
          
      87. Information about variants:
          Variants will be accepted: no
          
      88. Information about options:
          Options: no
      89. Information about electronic catalogues:
          
          
      90. Information about European Union funds:
          The procurement is related to a project and/or programme financed by European Union funds: no
      91. Additional information:
          
      92. Title:
          

          Kryzotynib

          Lot No: 8
          
      93. Additional CPV code(s):
          33652000
          
      94. Place of performance:
          Main site or place of performance:

          siedziba zamawiającego- Apteka szpitalna

      95. Description of the procurement:
          

          Kryzotynib

      96. Award criteria:
          
      97. Estimated value:
          
          
      98. Duration of the contract, framework agreement or dynamic purchasing system:
          Duration in months: 12
          This contract is subject to renewal: no
          
      99. Information about the limits on the number of candidates to be invited:
          
      100. Information about variants:
           Variants will be accepted: no
           
      101. Information about options:
           Options: no
      102. Information about electronic catalogues:
           
           
      103. Information about European Union funds:
           The procurement is related to a project and/or programme financed by European Union funds: no
      104. Additional information:
           
      105. Title:
           

           Ozymertynib

           Lot No: 9
           
      106. Additional CPV code(s):
           33652000
           
      107. Place of performance:
           Main site or place of performance:

           siedziba zamawiającego- Apteka szpitalna

      108. Description of the procurement:
           

           Ozymertynib

      109. Award criteria:
           
      110. Estimated value:
           
           
      111. Duration of the contract, framework agreement or dynamic purchasing system:
           Duration in months: 12
           This contract is subject to renewal: no
           
      112. Information about the limits on the number of candidates to be invited:
           
      113. Information about variants:
           Variants will be accepted: no
           
      114. Information about options:
           Options: no
      115. Information about electronic catalogues:
           
           
      116. Information about European Union funds:
           The procurement is related to a project and/or programme financed by European Union funds: no
      117. Additional information:
           
      118. Title:
           

           Atezolizumab

           Lot No: 10
           
      119. Additional CPV code(s):
           33652000
           
      120. Place of performance:
           Main site or place of performance:

           siedziba zamawiającego- Apteka szpitalna

      121. Description of the procurement:
           

           Atezolizumab

      122. Award criteria:
           
      123. Estimated value:
           
           
      124. Duration of the contract, framework agreement or dynamic purchasing system:
           Duration in months: 12
           This contract is subject to renewal: no
           
      125. Information about the limits on the number of candidates to be invited:
           
      126. Information about variants:
           Variants will be accepted: no
           
      127. Information about options:
           Options: no
      128. Information about electronic catalogues:
           
           
      129. Information about European Union funds:
           The procurement is related to a project and/or programme financed by European Union funds: no
      130. Additional information:
           
      131. Title:
           

           Afatynib

           Lot No: 11
           
      132. Additional CPV code(s):
           33652000
           
      133. Place of performance:
           Main site or place of performance:

           siedziba zamawiającego- Apteka szpitalna

      134. Description of the procurement:
           

           Afatynib

      135. Award criteria:
           
      136. Estimated value:
           
           
      137. Duration of the contract, framework agreement or dynamic purchasing system:
           Duration in months: 12
           This contract is subject to renewal: no
           
      138. Information about the limits on the number of candidates to be invited:
           
      139. Information about variants:
           Variants will be accepted: no
           
      140. Information about options:
           Options: no
      141. Information about electronic catalogues:
           
           
      142. Information about European Union funds:
           The procurement is related to a project and/or programme financed by European Union funds: no
      143. Additional information:
           
      144. Title:
           

           Nintedanib

           Lot No: 12
           
      145. Additional CPV code(s):
           33652000
           
      146. Place of performance:
           Main site or place of performance:

           siedziba zamawiającego- Apteka szpitalna

      147. Description of the procurement:
           

           Nintedanib

      148. Award criteria:
           
      149. Estimated value:
           
           
      150. Duration of the contract, framework agreement or dynamic purchasing system:
           Duration in months: 12
           This contract is subject to renewal: no
           
      151. Information about the limits on the number of candidates to be invited:
           
      152. Information about variants:
           Variants will be accepted: no
           
      153. Information about options:
           Options: no
      154. Information about electronic catalogues:
           
           
      155. Information about European Union funds:
           The procurement is related to a project and/or programme financed by European Union funds: no
      156. Additional information:
           
      157. Title:
           

           Alektynib

           Lot No: 13
           
      158. Additional CPV code(s):
           33652000
           
      159. Place of performance:
           Main site or place of performance:

           siedziba zamawiającego- Apteka szpitalna

      160. Description of the procurement:
           

           Alektynib

      161. Award criteria:
           
      162. Estimated value:
           
           
      163. Duration of the contract, framework agreement or dynamic purchasing system:
           Duration in months: 12
           This contract is subject to renewal: no
           
      164. Information about the limits on the number of candidates to be invited:
           
      165. Information about variants:
           Variants will be accepted: no
           
      166. Information about options:
           Options: no
      167. Information about electronic catalogues:
           
           
      168. Information about European Union funds:
           The procurement is related to a project and/or programme financed by European Union funds: no
      169. Additional information:
           
      170. Title:
           

           Cerytynib

           Lot No: 14
           
      171. Additional CPV code(s):
           33652000
           
      172. Place of performance:
           Main site or place of performance:

           siedziba zamawiającego- Apteka szpitalna

      173. Description of the procurement:
           

           Cerytynib

      174. Award criteria:
           
      175. Estimated value:
           
           
      176. Duration of the contract, framework agreement or dynamic purchasing system:
           Duration in months: 12
           This contract is subject to renewal: no
           
      177. Information about the limits on the number of candidates to be invited:
           
      178. Information about variants:
           Variants will be accepted: no
           
      179. Information about options:
           Options: no
      180. Information about electronic catalogues:
           
           
      181. Information about European Union funds:
           The procurement is related to a project and/or programme financed by European Union funds: no
      182. Additional information:
           
      183. Title:
           

           Brygatynib

           Lot No: 15
           
      184. Additional CPV code(s):
           33652000
           
      185. Place of performance:
           Main site or place of performance:

           siedziba zamawiającego- Apteka szpitalna

      186. Description of the procurement:
           

           Brygatynib

      187. Award criteria:
           
      188. Estimated value:
           
           
      189. Duration of the contract, framework agreement or dynamic purchasing system:
           Duration in months: 12
           This contract is subject to renewal: no
           
      190. Information about the limits on the number of candidates to be invited:
           
      191. Information about variants:
           Variants will be accepted: no
           
      192. Information about options:
           Options: no
      193. Information about electronic catalogues:
           
           
      194. Information about European Union funds:
           The procurement is related to a project and/or programme financed by European Union funds: no
      195. Additional information:
           
      196. Title:
           

           Durwalumab

           Lot No: 16
           
      197. Additional CPV code(s):
           33652000
           
      198. Place of performance:
           Main site or place of performance:

           siedziba zamawiającego- Apteka szpitalna

      199. Description of the procurement:
           

           Durwalumab

      200. Award criteria:
           
      201. Estimated value:
           
           
      202. Duration of the contract, framework agreement or dynamic purchasing system:
           Duration in months: 12
           This contract is subject to renewal: no
           
      203. Information about the limits on the number of candidates to be invited:
           
      204. Information about variants:
           Variants will be accepted: no
           
      205. Information about options:
           Options: no
      206. Information about electronic catalogues:
           
           
      207. Information about European Union funds:
           The procurement is related to a project and/or programme financed by European Union funds: no
      208. Additional information:
           
      209. Title:
           

           BCG Vaccinum

           Lot No: 17
           
      210. Additional CPV code(s):
           33652000
           
      211. Place of performance:
           Main site or place of performance:

           siedziba zamawiającego- Apteka szpitalna

      212. Description of the procurement:
           

           BCG Vaccinum

      213. Award criteria:
           
      214. Estimated value:
           
           
      215. Duration of the contract, framework agreement or dynamic purchasing system:
           Duration in months: 12
           This contract is subject to renewal: no
           
      216. Information about the limits on the number of candidates to be invited:
           
      217. Information about variants:
           Variants will be accepted: no
           
      218. Information about options:
           Options: no
      219. Information about electronic catalogues:
           
           
      220. Information about European Union funds:
           The procurement is related to a project and/or programme financed by European Union funds: no
      221. Additional information:
           
      222. Title:
           

           Lorlatynib

           Lot No: 18
           
      223. Additional CPV code(s):
           33652000
           
      224. Place of performance:
           Main site or place of performance:

           siedziba zamawiającego- Apteka szpitalna

      225. Description of the procurement:
           

           Lorlatynib

      226. Award criteria:
           
      227. Estimated value:
           
           
      228. Duration of the contract, framework agreement or dynamic purchasing system:
           Duration in months: 12
           This contract is subject to renewal: no
           
      229. Information about the limits on the number of candidates to be invited:
           
      230. Information about variants:
           Variants will be accepted: no
           
      231. Information about options:
           Options: no
      232. Information about electronic catalogues:
           
           
      233. Information about European Union funds:
           The procurement is related to a project and/or programme financed by European Union funds: no
      234. Additional information:
           
      235. Title:
           

           Entrectinibum

           Lot No: 19
           
      236. Additional CPV code(s):
           33652000
           
      237. Place of performance:
           Main site or place of performance:

           siedziba zamawiającego- Apteka szpitalna

      238. Description of the procurement:
           

           Entrectinibum

      239. Award criteria:
           
      240. Estimated value:
           
           
      241. Duration of the contract, framework agreement or dynamic purchasing system:
           Duration in months: 12
           This contract is subject to renewal: no
           
      242. Information about the limits on the number of candidates to be invited:
           
      243. Information about variants:
           Variants will be accepted: no
           
      244. Information about options:
           Options: no
      245. Information about electronic catalogues:
           
           
      246. Information about European Union funds:
           The procurement is related to a project and/or programme financed by European Union funds: no
      247. Additional information:
           
      248. Title:
           

           Cemiplimab

           Lot No: 20
           
      249. Additional CPV code(s):
           33652000
           
      250. Place of performance:
           Main site or place of performance:

           siedziba zamawiającego- Apteka szpitalna

      251. Description of the procurement:
           

           Cemiplimab

      252. Award criteria:
           
      253. Estimated value:
           
           
      254. Duration of the contract, framework agreement or dynamic purchasing system:
           Duration in months: 12
           This contract is subject to renewal: no
           
      255. Information about the limits on the number of candidates to be invited:
           
      256. Information about variants:
           Variants will be accepted: no
           
      257. Information about options:
           Options: no
      258. Information about electronic catalogues:
           
           
      259. Information about European Union funds:
           The procurement is related to a project and/or programme financed by European Union funds: no
      260. Additional information:
           
      261. Title:
           

           Trastuzumab

           Lot No: 21
           
      262. Additional CPV code(s):
           33652000
           
      263. Place of performance:
           Main site or place of performance:

           siedziba zamawiającego- Apteka szpitalna

      264. Description of the procurement:
           

           Trastuzumab

      265. Award criteria:
           
      266. Estimated value:
           
           
      267. Duration of the contract, framework agreement or dynamic purchasing system:
           Duration in months: 12
           This contract is subject to renewal: no
           
      268. Information about the limits on the number of candidates to be invited:
           
      269. Information about variants:
           Variants will be accepted: no
           
      270. Information about options:
           Options: no
      271. Information about electronic catalogues:
           
           
      272. Information about European Union funds:
           The procurement is related to a project and/or programme financed by European Union funds: no
      273. Additional information:
           
      274. Title:
           

           Lapatynib

           Lot No: 22
           
      275. Additional CPV code(s):
           33652000
           
      276. Place of performance:
           Main site or place of performance:

           siedziba zamawiającego- Apteka szpitalna

      277. Description of the procurement:
           

           Lapatynib

      278. Award criteria:
           
      279. Estimated value:
           
           
      280. Duration of the contract, framework agreement or dynamic purchasing system:
           Duration in months: 12
           This contract is subject to renewal: no
           
      281. Information about the limits on the number of candidates to be invited:
           
      282. Information about variants:
           Variants will be accepted: no
           
      283. Information about options:
           Options: no
      284. Information about electronic catalogues:
           
           
      285. Information about European Union funds:
           The procurement is related to a project and/or programme financed by European Union funds: no
      286. Additional information:
           
      287. Title:
           

           Pertuzumab

           Lot No: 23
           
      288. Additional CPV code(s):
           33652000
           
      289. Place of performance:
           Main site or place of performance:

           siedziba zamawiającego- Apteka szpitalna

      290. Description of the procurement:
           

           Pertuzumab

      291. Award criteria:
           
      292. Estimated value:
           
           
      293. Duration of the contract, framework agreement or dynamic purchasing system:
           Duration in months: 12
           This contract is subject to renewal: no
           
      294. Information about the limits on the number of candidates to be invited:
           
      295. Information about variants:
           Variants will be accepted: no
           
      296. Information about options:
           Options: no
      297. Information about electronic catalogues:
           
           
      298. Information about European Union funds:
           The procurement is related to a project and/or programme financed by European Union funds: no
      299. Additional information:
           
      300. Title:
           

           Palbocyklib

           Lot No: 24
           
      301. Additional CPV code(s):
           33652000
           
      302. Place of performance:
           Main site or place of performance:

           siedziba zamawiającego- Apteka szpitalna

      303. Description of the procurement:
           

           Palbocyklib

      304. Award criteria:
           
      305. Estimated value:
           
           
      306. Duration of the contract, framework agreement or dynamic purchasing system:
           Duration in months: 12
           This contract is subject to renewal: no
           
      307. Information about the limits on the number of candidates to be invited:
           
      308. Information about variants:
           Variants will be accepted: no
           
      309. Information about options:
           Options: no
      310. Information about electronic catalogues:
           
           
      311. Information about European Union funds:
           The procurement is related to a project and/or programme financed by European Union funds: no
      312. Additional information:
           
      313. Title:
           

           Rybocyklib

           Lot No: 25
           
      314. Additional CPV code(s):
           33652000
           
      315. Place of performance:
           Main site or place of performance:

           siedziba zamawiającego- Apteka szpitalna

      316. Description of the procurement:
           

           Rybocyklib

      317. Award criteria:
           
      318. Estimated value:
           
           
      319. Duration of the contract, framework agreement or dynamic purchasing system:
           Duration in months: 12
           This contract is subject to renewal: no
           
      320. Information about the limits on the number of candidates to be invited:
           
      321. Information about variants:
           Variants will be accepted: no
           
      322. Information about options:
           Options: no
      323. Information about electronic catalogues:
           
           
      324. Information about European Union funds:
           The procurement is related to a project and/or programme financed by European Union funds: no
      325. Additional information:
           
      326. Title:
           

           Trastuzumab emtanzyna

           Lot No: 26
           
      327. Additional CPV code(s):
           33652000
           
      328. Place of performance:
           Main site or place of performance:

           siedziba zamawiającego- Apteka szpitalna

      329. Description of the procurement:
           

           Trastuzumab emtanzyna

      330. Award criteria:
           
      331. Estimated value:
           
           
      332. Duration of the contract, framework agreement or dynamic purchasing system:
           Duration in months: 12
           This contract is subject to renewal: no
           
      333. Information about the limits on the number of candidates to be invited:
           
      334. Information about variants:
           Variants will be accepted: no
           
      335. Information about options:
           Options: no
      336. Information about electronic catalogues:
           
           
      337. Information about European Union funds:
           The procurement is related to a project and/or programme financed by European Union funds: no
      338. Additional information:
           
      339. Title:
           

           Abemacyklib

           Lot No: 27
           
      340. Additional CPV code(s):
           33652000
           
      341. Place of performance:
           Main site or place of performance:

           siedziba zamawiającego- Apteka szpitalna

      342. Description of the procurement:
           

           Abemacyklib

      343. Award criteria:
           
      344. Estimated value:
           
           
      345. Duration of the contract, framework agreement or dynamic purchasing system:
           Duration in months: 12
           This contract is subject to renewal: no
           
      346. Information about the limits on the number of candidates to be invited:
           
      347. Information about variants:
           Variants will be accepted: no
           
      348. Information about options:
           Options: no
      349. Information about electronic catalogues:
           
           
      350. Information about European Union funds:
           The procurement is related to a project and/or programme financed by European Union funds: no
      351. Additional information:
           
      352. Title:
           

           Alpelisyb

           Lot No: 28
           
      353. Additional CPV code(s):
           33652000
           
      354. Place of performance:
           Main site or place of performance:

           siedziba zamawiającego- Apteka szpitalna

      355. Description of the procurement:
           

           Alpelisyb

      356. Award criteria:
           
      357. Estimated value:
           
           
      358. Duration of the contract, framework agreement or dynamic purchasing system:
           Duration in months: 12
           This contract is subject to renewal: no
           
      359. Information about the limits on the number of candidates to be invited:
           
      360. Information about variants:
           Variants will be accepted: no
           
      361. Information about options:
           Options: no
      362. Information about electronic catalogues:
           
           
      363. Information about European Union funds:
           The procurement is related to a project and/or programme financed by European Union funds: no
      364. Additional information:
           
      365. Title:
           

           Sacytuzumab gowitekan

           Lot No: 29
           
      366. Additional CPV code(s):
           33652000
           
      367. Place of performance:
           Main site or place of performance:

           siedziba zamawiającego- Apteka szpitalna

      368. Description of the procurement:
           

           Sacytuzumab gowitekan

      369. Award criteria:
           
      370. Estimated value:
           
           
      371. Duration of the contract, framework agreement or dynamic purchasing system:
           Duration in months: 12
           This contract is subject to renewal: no
           
      372. Information about the limits on the number of candidates to be invited:
           
      373. Information about variants:
           Variants will be accepted: no
           
      374. Information about options:
           Options: no
      375. Information about electronic catalogues:
           
           
      376. Information about European Union funds:
           The procurement is related to a project and/or programme financed by European Union funds: no
      377. Additional information:
           
      378. Title:
           

           Talazoparyb

           Lot No: 30
           
      379. Additional CPV code(s):
           33652000
           
      380. Place of performance:
           Main site or place of performance:

           siedziba zamawiającego- Apteka szpitalna

      381. Description of the procurement:
           

           Talazoparyb

      382. Award criteria:
           
      383. Estimated value:
           
           
      384. Duration of the contract, framework agreement or dynamic purchasing system:
           Duration in months: 12
           This contract is subject to renewal: no
           
      385. Information about the limits on the number of candidates to be invited:
           
      386. Information about variants:
           Variants will be accepted: no
           
      387. Information about options:
           Options: no
      388. Information about electronic catalogues:
           
           
      389. Information about European Union funds:
           The procurement is related to a project and/or programme financed by European Union funds: no
      390. Additional information:
           
      391. Title:
           

           Piksantronu dimaleinian

           Lot No: 31
           
      392. Additional CPV code(s):
           33652000
           
      393. Place of performance:
           Main site or place of performance:

           siedziba zamawiającego- Apteka szpitalna

      394. Description of the procurement:
           

           Piksantronu dimaleinian

      395. Award criteria:
           
      396. Estimated value:
           
           
      397. Duration of the contract, framework agreement or dynamic purchasing system:
           Duration in months: 12
           This contract is subject to renewal: no
           
      398. Information about the limits on the number of candidates to be invited:
           
      399. Information about variants:
           Variants will be accepted: no
           
      400. Information about options:
           Options: no
      401. Information about electronic catalogues:
           
           
      402. Information about European Union funds:
           The procurement is related to a project and/or programme financed by European Union funds: no
      403. Additional information:
           
      404. Title:
           

           Polatuzumab wedotyny

           Lot No: 32
           
      405. Additional CPV code(s):
           33652000
           
      406. Place of performance:
           Main site or place of performance:

           siedziba zamawiającego- Apteka szpitalna

      407. Description of the procurement:
           

           Polatuzumab wedotyny

      408. Award criteria:
           
      409. Estimated value:
           
           
      410. Duration of the contract, framework agreement or dynamic purchasing system:
           Duration in months: 12
           This contract is subject to renewal: no
           
      411. Information about the limits on the number of candidates to be invited:
           
      412. Information about variants:
           Variants will be accepted: no
           
      413. Information about options:
           Options: no
      414. Information about electronic catalogues:
           
           
      415. Information about European Union funds:
           The procurement is related to a project and/or programme financed by European Union funds: no
      416. Additional information:
           
      417. Title:
           

           Tafasitamabum

           Lot No: 33
           
      418. Additional CPV code(s):
           33652000
           
      419. Place of performance:
           Main site or place of performance:

           siedziba zamawiającego- Apteka szpitalna

      420. Description of the procurement:
           

           Tafasitamabum

      421. Award criteria:
           
      422. Estimated value:
           
           
      423. Duration of the contract, framework agreement or dynamic purchasing system:
           Duration in months: 12
           This contract is subject to renewal: no
           
      424. Information about the limits on the number of candidates to be invited:
           
      425. Information about variants:
           Variants will be accepted: no
           
      426. Information about options:
           Options: no
      427. Information about electronic catalogues:
           
           
      428. Information about European Union funds:
           The procurement is related to a project and/or programme financed by European Union funds: no
      429. Additional information:
           
      430. Title:
           

           Ibrutynib

           Lot No: 34
           
      431. Additional CPV code(s):
           33652000
           
      432. Place of performance:
           Main site or place of performance:

           siedziba zamawiającego- Apteka szpitalna

      433. Description of the procurement:
           

           Ibrutynib

      434. Award criteria:
           
      435. Estimated value:
           
           
      436. Duration of the contract, framework agreement or dynamic purchasing system:
           Duration in months: 12
           This contract is subject to renewal: no
           
      437. Information about the limits on the number of candidates to be invited:
           
      438. Information about variants:
           Variants will be accepted: no
           
      439. Information about options:
           Options: no
      440. Information about electronic catalogues:
           
           
      441. Information about European Union funds:
           The procurement is related to a project and/or programme financed by European Union funds: no
      442. Additional information:
           
      443. Title:
           

           Obinutuzumab

           Lot No: 35
           
      444. Additional CPV code(s):
           33652000
           
      445. Place of performance:
           Main site or place of performance:

           siedziba zamawiającego- Apteka szpitalna

      446. Description of the procurement:
           

           Obinutuzumab

      447. Award criteria:
           
      448. Estimated value:
           
           
      449. Duration of the contract, framework agreement or dynamic purchasing system:
           Duration in months: 12
           This contract is subject to renewal: no
           
      450. Information about the limits on the number of candidates to be invited:
           
      451. Information about variants:
           Variants will be accepted: no
           
      452. Information about options:
           Options: no
      453. Information about electronic catalogues:
           
           
      454. Information about European Union funds:
           The procurement is related to a project and/or programme financed by European Union funds: no
      455. Additional information:
           
      456. Title:
           

           Dazatynib

           Lot No: 36
           
      457. Additional CPV code(s):
           33652000
           
      458. Place of performance:
           Main site or place of performance:

           siedziba zamawiającego- Apteka szpitalna

      459. Description of the procurement:
           

           Dazatynib

      460. Award criteria:
           
      461. Estimated value:
           
           
      462. Duration of the contract, framework agreement or dynamic purchasing system:
           Duration in months: 12
           This contract is subject to renewal: no
           
      463. Information about the limits on the number of candidates to be invited:
           
      464. Information about variants:
           Variants will be accepted: no
           
      465. Information about options:
           Options: no
      466. Information about electronic catalogues:
           
           
      467. Information about European Union funds:
           The procurement is related to a project and/or programme financed by European Union funds: no
      468. Additional information:
           
      469. Title:
           

           Nilotynib

           Lot No: 37
           
      470. Additional CPV code(s):
           33652000
           
      471. Place of performance:
           Main site or place of performance:

           siedziba zamawiającego- Apteka szpitalna

      472. Description of the procurement:
           

           Nilotynib

      473. Award criteria:
           
      474. Estimated value:
           
           
      475. Duration of the contract, framework agreement or dynamic purchasing system:
           Duration in months: 12
           This contract is subject to renewal: no
           
      476. Information about the limits on the number of candidates to be invited:
           
      477. Information about variants:
           Variants will be accepted: no
           
      478. Information about options:
           Options: no
      479. Information about electronic catalogues:
           
           
      480. Information about European Union funds:
           The procurement is related to a project and/or programme financed by European Union funds: no
      481. Additional information:
           
      482. Title:
           

           Bosutynib

           Lot No: 38
           
      483. Additional CPV code(s):
           33652000
           
      484. Place of performance:
           Main site or place of performance:

           siedziba zamawiającego- Apteka szpitalna

      485. Description of the procurement:
           

           Bosutynib

      486. Award criteria:
           
      487. Estimated value:
           
           
      488. Duration of the contract, framework agreement or dynamic purchasing system:
           Duration in months: 12
           This contract is subject to renewal: no
           
      489. Information about the limits on the number of candidates to be invited:
           
      490. Information about variants:
           Variants will be accepted: no
           
      491. Information about options:
           Options: no
      492. Information about electronic catalogues:
           
           
      493. Information about European Union funds:
           The procurement is related to a project and/or programme financed by European Union funds: no
      494. Additional information:
           
      495. Title:
           

           Ponatynib

           Lot No: 39
           
      496. Additional CPV code(s):
           33652000
           
      497. Place of performance:
           Main site or place of performance:

           siedziba zamawiającego- Apteka szpitalna

      498. Description of the procurement:
           

           Ponatynib

      499. Award criteria:
           
      500. Estimated value:
           
           
      501. Duration of the contract, framework agreement or dynamic purchasing system:
           Duration in months: 12
           This contract is subject to renewal: no
           
      502. Information about the limits on the number of candidates to be invited:
           
      503. Information about variants:
           Variants will be accepted: no
           
      504. Information about options:
           Options: no
      505. Information about electronic catalogues:
           
           
      506. Information about European Union funds:
           The procurement is related to a project and/or programme financed by European Union funds: no
      507. Additional information:
           
      508. Title:
           

           Olaparyb

           Lot No: 40
           
      509. Additional CPV code(s):
           33652000
           
      510. Place of performance:
           Main site or place of performance:

           siedziba zamawiającego- Apteka szpitalna

      511. Description of the procurement:
           

           Olaparyb

      512. Award criteria:
           
      513. Estimated value:
           
           
      514. Duration of the contract, framework agreement or dynamic purchasing system:
           Duration in months: 12
           This contract is subject to renewal: no
           
      515. Information about the limits on the number of candidates to be invited:
           
      516. Information about variants:
           Variants will be accepted: no
           
      517. Information about options:
           Options: no
      518. Information about electronic catalogues:
           
           
      519. Information about European Union funds:
           The procurement is related to a project and/or programme financed by European Union funds: no
      520. Additional information:
           
      521. Title:
           

           Niraparyb

           Lot No: 41
           
      522. Additional CPV code(s):
           33652000
           
      523. Place of performance:
           Main site or place of performance:

           siedziba zamawiającego- Apteka szpitalna

      524. Description of the procurement:
           

           Niraparyb

      525. Award criteria:
           
      526. Estimated value:
           
           
      527. Duration of the contract, framework agreement or dynamic purchasing system:
           Duration in months: 12
           This contract is subject to renewal: no
           
      528. Information about the limits on the number of candidates to be invited:
           
      529. Information about variants:
           Variants will be accepted: no
           
      530. Information about options:
           Options: no
      531. Information about electronic catalogues:
           
           
      532. Information about European Union funds:
           The procurement is related to a project and/or programme financed by European Union funds: no
      533. Additional information:
           
      534. Title:
           

           Pomalidomid

           Lot No: 42
           
      535. Additional CPV code(s):
           33652000
           
      536. Place of performance:
           Main site or place of performance:

           siedziba zamawiającego- Apteka szpitalna

      537. Description of the procurement:
           

           Pomalidomid

      538. Award criteria:
           
      539. Estimated value:
           
           
      540. Duration of the contract, framework agreement or dynamic purchasing system:
           Duration in months: 12
           This contract is subject to renewal: no
           
      541. Information about the limits on the number of candidates to be invited:
           
      542. Information about variants:
           Variants will be accepted: no
           
      543. Information about options:
           Options: no
      544. Information about electronic catalogues:
           
           
      545. Information about European Union funds:
           The procurement is related to a project and/or programme financed by European Union funds: no
      546. Additional information:
           
      547. Title:
           

           Daratumumab

           Lot No: 43
           
      548. Additional CPV code(s):
           33652000
           
      549. Place of performance:
           Main site or place of performance:

           siedziba zamawiającego- Apteka szpitalna

      550. Description of the procurement:
           

           Daratumumab

      551. Award criteria:
           
      552. Estimated value:
           
           
      553. Duration of the contract, framework agreement or dynamic purchasing system:
           Duration in months: 12
           This contract is subject to renewal: no
           
      554. Information about the limits on the number of candidates to be invited:
           
      555. Information about variants:
           Variants will be accepted: no
           
      556. Information about options:
           Options: no
      557. Information about electronic catalogues:
           
           
      558. Information about European Union funds:
           The procurement is related to a project and/or programme financed by European Union funds: no
      559. Additional information:
           
      560. Title:
           

           Karfilzomib

           Lot No: 44
           
      561. Additional CPV code(s):
           33652000
           
      562. Place of performance:
           Main site or place of performance:

           siedziba zamawiającego- Apteka szpitalna

      563. Description of the procurement:
           

           Karfilzomib

      564. Award criteria:
           
      565. Estimated value:
           
           
      566. Duration of the contract, framework agreement or dynamic purchasing system:
           Duration in months: 12
           This contract is subject to renewal: no
           
      567. Information about the limits on the number of candidates to be invited:
           
      568. Information about variants:
           Variants will be accepted: no
           
      569. Information about options:
           Options: no
      570. Information about electronic catalogues:
           
           
      571. Information about European Union funds:
           The procurement is related to a project and/or programme financed by European Union funds: no
      572. Additional information:
           
      573. Title:
           

           Iksazomib

           Lot No: 45
           
      574. Additional CPV code(s):
           33652000
           
      575. Place of performance:
           Main site or place of performance:

           siedziba zamawiającego- Apteka szpitalna

      576. Description of the procurement:
           

           Iksazomib

      577. Award criteria:
           
      578. Estimated value:
           
           
      579. Duration of the contract, framework agreement or dynamic purchasing system:
           Duration in months: 12
           This contract is subject to renewal: no
           
      580. Information about the limits on the number of candidates to be invited:
           
      581. Information about variants:
           Variants will be accepted: no
           
      582. Information about options:
           Options: no
      583. Information about electronic catalogues:
           
           
      584. Information about European Union funds:
           The procurement is related to a project and/or programme financed by European Union funds: no
      585. Additional information:
           
      586. Title:
           

           Elotuzumabum

           Lot No: 46
           
      587. Additional CPV code(s):
           33652000
           
      588. Place of performance:
           Main site or place of performance:

           siedziba zamawiającego- Apteka szpitalna

      589. Description of the procurement:
           

           Elotuzumabum

      590. Award criteria:
           
      591. Estimated value:
           
           
      592. Duration of the contract, framework agreement or dynamic purchasing system:
           Duration in months: 12
           This contract is subject to renewal: no
           
      593. Information about the limits on the number of candidates to be invited:
           
      594. Information about variants:
           Variants will be accepted: no
           
      595. Information about options:
           Options: no
      596. Information about electronic catalogues:
           
           
      597. Information about European Union funds:
           The procurement is related to a project and/or programme financed by European Union funds: no
      598. Additional information:
           
      599. Title:
           

           Enzalutamid

           Lot No: 47
           
      600. Additional CPV code(s):
           33652000
           
      601. Place of performance:
           Main site or place of performance:

           siedziba zamawiającego- Apteka szpitalna

      602. Description of the procurement:
           

           Enzalutamid

      603. Award criteria:
           
      604. Estimated value:
           
           
      605. Duration of the contract, framework agreement or dynamic purchasing system:
           Duration in months: 12
           This contract is subject to renewal: no
           
      606. Information about the limits on the number of candidates to be invited:
           
      607. Information about variants:
           Variants will be accepted: no
           
      608. Information about options:
           Options: no
      609. Information about electronic catalogues:
           
           
      610. Information about European Union funds:
           The procurement is related to a project and/or programme financed by European Union funds: no
      611. Additional information:
           
      612. Title:
           

           Apalutamid

           Lot No: 48
           
      613. Additional CPV code(s):
           33652000
           
      614. Place of performance:
           Main site or place of performance:

           siedziba zamawiającego- Apteka szpitalna

      615. Description of the procurement:
           

           Apalutamid

      616. Award criteria:
           
      617. Estimated value:
           
           
      618. Duration of the contract, framework agreement or dynamic purchasing system:
           Duration in months: 12
           This contract is subject to renewal: no
           
      619. Information about the limits on the number of candidates to be invited:
           
      620. Information about variants:
           Variants will be accepted: no
           
      621. Information about options:
           Options: no
      622. Information about electronic catalogues:
           
           
      623. Information about European Union funds:
           The procurement is related to a project and/or programme financed by European Union funds: no
      624. Additional information:
           
      625. Title:
           

           Darolutamid

           Lot No: 49
           
      626. Additional CPV code(s):
           33652000
           
      627. Place of performance:
           Main site or place of performance:

           siedziba zamawiającego- Apteka szpitalna

      628. Description of the procurement:
           

           Darolutamid

      629. Award criteria:
           
      630. Estimated value:
           
           
      631. Duration of the contract, framework agreement or dynamic purchasing system:
           Duration in months: 12
           This contract is subject to renewal: no
           
      632. Information about the limits on the number of candidates to be invited:
           
      633. Information about variants:
           Variants will be accepted: no
           
      634. Information about options:
           Options: no
      635. Information about electronic catalogues:
           
           
      636. Information about European Union funds:
           The procurement is related to a project and/or programme financed by European Union funds: no
      637. Additional information:
           
      638. Title:
           

           Kabazytaksel

           Lot No: 50
           
      639. Additional CPV code(s):
           33652000
           
      640. Place of performance:
           Main site or place of performance:

           siedziba zamawiającego- Apteka szpitalna

      641. Description of the procurement:
           

           Kabazytaksel

      642. Award criteria:
           
      643. Estimated value:
           
           
      644. Duration of the contract, framework agreement or dynamic purchasing system:
           Duration in months: 12
           This contract is subject to renewal: no
           
      645. Information about the limits on the number of candidates to be invited:
           
      646. Information about variants:
           Variants will be accepted: no
           
      647. Information about options:
           Options: no
      648. Information about electronic catalogues:
           
           
      649. Information about European Union funds:
           The procurement is related to a project and/or programme financed by European Union funds: no
      650. Additional information:
           
      651. Title:
           

           Ramucyrumab

           Lot No: 51
           
      652. Additional CPV code(s):
           33652000
           
      653. Place of performance:
           Main site or place of performance:

           siedziba zamawiającego- Apteka szpitalna

      654. Description of the procurement:
           

           Ramucyrumab

      655. Award criteria:
           
      656. Estimated value:
           
           
      657. Duration of the contract, framework agreement or dynamic purchasing system:
           Duration in months: 12
           This contract is subject to renewal: no
           
      658. Information about the limits on the number of candidates to be invited:
           
      659. Information about variants:
           Variants will be accepted: no
           
      660. Information about options:
           Options: no
      661. Information about electronic catalogues:
           
           
      662. Information about European Union funds:
           The procurement is related to a project and/or programme financed by European Union funds: no
      663. Additional information:
           
      664. Title:
           

           Blinatumomab

           Lot No: 52
           

Источник закупки

Импорт - Экспорт по стране Польша